Immediate Impact
1 from Science/Nature 13 standout
Citing Papers
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial
2024 Standout
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
2023 Standout
Works of Alina Buture being referenced
Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Alina Buture | 169 | 106 | 76 | 15 | 194 | |
| Marina Janelidze | 217 | 152 | 98 | 18 | 269 | |
| G. Latorre | 145 | 91 | 59 | 21 | 215 | |
| Soma Sahai‐Srivastava | 191 | 163 | 83 | 15 | 262 | |
| Marianna Nicodemo | 231 | 115 | 96 | 17 | 285 | |
| Susan W. Broner | 211 | 88 | 40 | 17 | 260 | |
| Ivano Farinelli | 126 | 63 | 71 | 11 | 185 | |
| Lili Kokoti | 198 | 111 | 66 | 15 | 248 | |
| Carmen García‐Cabo | 106 | 70 | 42 | 22 | 235 | |
| Anker Stubberud | 208 | 72 | 45 | 21 | 295 | |
| Paulo Hélio Monzillo | 242 | 181 | 58 | 19 | 292 |
All Works
Login with ORCID to disown or claim papers
Loading papers...